Fractionation of the liver membrane lipoprotein (LSP) and characterisation of its antigenic determinants by autoantibodies and a heterologous anti-serum M MANNS AND K-H MEYER ZUM BUSCHENFELDE* From the First Department ofInternal Medicine and Policlinic, University of Mainz, Mainz, Federal Republic of Germany SUMMARY Sera from 50 patients with chronic active liver disease were investigated by radioimmunoprecipitation test for autoantibodies against human and rabbit liver membrane lipoprotein (LSP), and a human kidney equivalent protein. Twenty-one of 50 chronic active liver disease sera were positive for autoantibodies against human liver membrane lipoprotein. Eleven of 50 sera reacted with rabbit liver membrane lipoprotein and four of 50 sera with human kidney equivalent protein as well. In order to identify the antigenic determinants of these autoantibodies '251-labelled human and rabbit liver membrane lipoprotein and human kidney equivalent protein were fractionated by CsCl density gradient centrifugation. Distribution of labelled antigen fractions in density gradients revealed two peaks with maximum radioactivity at 1.34 and 1. 11 g/ml. Density gradient fractions were assayed for antigen activity by radioimmunoprecipitation test using autoantibody positive sera of patients with chronic active liver disease. Anti-human and anti-rabbit liver membrane lipoprotein and anti-human kidney equivalent protein positive human sera all localised their corresponding determinants in the low density fractions (1X08-1.10 g/ml). An antiserum against human liver membrane lipoprotein, raised in rabbits after short-term immunisation, recognised the low density '251-human liver membrane lipoprotein subfraction. This serum had previously been absorbed with human kidney homogenate, plasma, and blood cells. Thus, organ-specific and non-organ-specific determinants were both localised in the low density liver membrane lipoprotein subfraction. They could not be separated by the described fractionation procedure. It is to be supposed that organ-specific determinants ofa low density membrane protein of hepatocytes are targets of circulating autoantibodies in chronic active liver disease. 0.02 M NaCI, 0. 1 M EDTA, and 01% N BSA at densities of 1.28 g/ml (solution 1), 1-16 g/ml (solution 2) 108 g/ml (solution 3), and 1.04 g/ml (solution 4). Densities were determined from their refractive indices by a Zeiss refractometer. The CsCI density gradient was prepared in 12 ml tubes by sequentially overlaying 4.0 ml of solution 1, containing 6 jg of labelled antigen protein, 4.5 ml of solution 2, 2.5 ml of solution 3, and 10 ml of solution 4. Tubes were centrifuged in a Beckman SW 41 rotor at 30000 rpm for 24 hours. After centrifugation fractions were taken by bottom puncture of the tubes and measured for density and radioactivity. Antigen activity of density gradient fractions was tested by RIP (Table) . Fig. 2A . The four chronic active liver disease sera reacting with HKP (Table) reacted with the low density fractions of CsCI density gradient of HKP as well. Figure 2B shows one representative anti-HKP positive serum and two sera that reacted neither with HKP nor with fractions of CsCI density gradient of labelled HKP but with the low density fractions of human LSP. Thus organ-specific and non-organspecific determinants of the LSP fraction were both localised in the low density fractions of CsCI density gradient. (Fig. 3) . Negative results were obtained with LSP preparations from other species. Absorption of antiserum was proved by testing density gradient fractions of 1251-HKP under equivalent conditions. All these studies gave negative results. Thus absorbed rabbit anti-human LSP serum obtained after short-term immunisation recognises a species-and organ-specific determinant which is localised in the low density subfraction of the human LSP preparation.
Discussion
At present investigations on humoral and cellmediated immune reactions are performed with the whole LSP fraction as antigen. These antigen fractions are prepared by the technique described by McFarlane et al.3 In order to define and identify antigenic determinants within the LSP fraction, human LSP, rabbit LSP, and HKP were fractionated by density gradient centrifugation. All fractions were tested by -0 radioimmunoprecipitation test using autoantibodies of sera from patients with chronic active liver disease and absorbed rabbit anti-human LSP serum. The 21 sera containing anti-human LSP autoantibodies (Table) recognised only a low density 25I-human-LSP-subfraction (1.08-1 10 g/ml) obtained after CsCI density gradient centrifugation. Labelled rabbit LSP and HKP were also submitted to CsCI density gradient centrifugation. The distribution of I251-rabbit LSP and '25P-HKP in CsCI density gradients was similar when compared with human LSP. The 11 sera positive for anti-rabbit LSP and the four anti-HKP positive sera reacted with the low density subfraction of rabbit LSP and HKP, respectively. Thus autoantibodies in sera from patients with chronic active liver disease predominantly react with organ-specific determinants of LSP fractions of different species. Only four of 21 antihuman LSP positive sera reacted with non-organspecific determinants of the low density LSP subfraction. It can be concluded from these data that species-specific and non-species-specific determinants of a low density protein are targets for autoantibodies in human inflammatory liver diseases.
Heterologous anti-LSP serum, originally used to identify the organ-specific determinant, reacted with the low density gradient fractions of human LSP as well. This serum, obtained after short-term immunisation, detects an organ-and species-specific determinant, which is in accordance with previous investigations, when crossed immunoelectrophoresis was used to characterise heterologous anti-LSP sera. 7 In this study, sera from rabbits with experimentally induced chronic hepatitis were shown to contain anti-LSP antibodies reacting with non-species-specific determinants.
The techniques used so far have been unable physically to separate the organ-specific and nonorgan-specific determinants. The possibility that organ-specific and non-organ-specific determinants are both located on an identical molecule of a lipoprotein nature should be considered. Further studies are needed to clarify whether or not antibodies in patients' sera and heteroimmune sera are partially directed against identical determinants. Recently DeKretser et al.20 demonstrated the membraneassociation of an LSP determinant which was recognised by absorbed heterologous anti-serum and autoantibodies. In immunodiffusion studies guineapig anti-LSP serum and sera from patients with HBsAg positive and negative chronic active hepatitis reacted with one precipitin line with total rabbit LSP fraction and a plasma membrane fraction isolated from normal rabbit liver. These studies confirm the membrane association of a liver-specific determinant and give evidence that autoantibodies are directed against at least one organ-specific determinant detected by heteroimmune sera.
The data that are presented describe a low density liver protein fraction as target antigen of human autoantibodies in chronic active liver disease. This protein fraction bears a liver specific determinant detected by human autoantibodies and absorbed heterologous antiserum.
Although, in addition to our studies, biochemical and immunochemical characterisation of the low density liver protein fraction may be necessary, it has become less speculative that an organ-specific determinant of the liver cell membrane is involved in immune processes of human inflammatory liver diseases. Nevertheless, it has to be proved whether there is, in fact, a causal link between the described immune phenomena and hepatocellular injury. 
